Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hamann

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|November 27, 2023
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)Young Chen, Brandon Whitefield, Erin Nevius, et al.
Nature|April 23, 2010
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectMin Gao, Richard E Nettles, Makonen Belema, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2018
Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase InhibitorMartin L Marro, Andrew W Patterson, Lac Lee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 2016
Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine δ-Oxidation and RearrangementWenying Li, Weiping Zhao, Xiaohong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolaseKarnail S Atwal, Saleem Ahmad, Charles Z Ding, et al.
Nature Chemical Biology|September 8, 2018
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrateMary E Matyskiela, Suzana Couto, Xinde Zheng, et al.
Plos One|November 9, 2021
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivoSteven A Saenz, Andrea Local, Tiffany Carr, et al.
Journal of Medicinal Chemistry|June 8, 2007
Discovery of potent and muscle selective androgen receptor modulators through scaffold modificationsJames J Li, James C Sutton, Alexandra Nirschl, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulatorsLawrence G Hamann, Mark C Manfredi, Chongqing Sun, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|November 27, 2023
Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2)Young Chen, Brandon Whitefield, Erin Nevius, et al.
Nature|April 23, 2010
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectMin Gao, Richard E Nettles, Makonen Belema, et al.
Journal of Medicinal Chemistry|December 22, 2006
Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffoldChongqing Sun, Jeffrey A Robl, Tammy C Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2018
Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase InhibitorMartin L Marro, Andrew W Patterson, Lac Lee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 2016
Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine δ-Oxidation and RearrangementWenying Li, Weiping Zhao, Xiaohong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolaseKarnail S Atwal, Saleem Ahmad, Charles Z Ding, et al.
Nature Chemical Biology|September 8, 2018
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrateMary E Matyskiela, Suzana Couto, Xinde Zheng, et al.
Plos One|November 9, 2021
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivoSteven A Saenz, Andrea Local, Tiffany Carr, et al.
Journal of Medicinal Chemistry|June 8, 2007
Discovery of potent and muscle selective androgen receptor modulators through scaffold modificationsJames J Li, James C Sutton, Alexandra Nirschl, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulatorsLawrence G Hamann, Mark C Manfredi, Chongqing Sun, et al.
Pageof 12